HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Kaneda Selected Research

Vecuronium Bromide (Vecuronium)

1/2019Retraction notice to "Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus" [Br J Anaesth 2003; 90: 480-486].
2/2014Vecuronium pharmacokinetics in patients with major burns.
4/2003Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus.
1/2002The effect of ulinastatin pre-treatment on vecuronium-induced neuromuscular block in patients with hepatic cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Kaneda Research Topics

Disease

5Body Weight (Weight, Body)
10/2001 - 01/2000
4Neoplasms (Cancer)
06/2011 - 12/2000
4Fibrosis (Cirrhosis)
01/2002 - 11/2000
3Rheumatoid Arthritis
03/2008 - 01/2000
3Hypersensitivity (Allergy)
09/2003 - 02/2001
3Choroidal Neovascularization
10/2001 - 01/2000
3Inflammation (Inflammations)
05/2001 - 01/2000
2Diabetes Mellitus
01/2019 - 04/2003
2Cerebral Infarction
01/2012 - 04/2011
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2011 - 12/2001
2Chronic Kidney Failure (Chronic Renal Failure)
04/2011 - 08/2004
2Type 2 Diabetes Mellitus (MODY)
09/2007 - 04/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2006 - 09/2002
2Infections
02/2001 - 04/2000
2Osteoarthritis
12/2000 - 01/2000
1Burns
02/2014
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2012
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2011
1Leukemia
06/2011
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2011
1Hypertension (High Blood Pressure)
04/2011
1Myocardial Infarction
12/2009
1Aneurysm (Aneurysms)
12/2009
1Insulin Resistance
09/2007
1Autoimmune Diseases (Autoimmune Disease)
10/2006
1Parkinson Disease (Parkinson's Disease)
12/2005
1Melanoma (Melanoma, Malignant)
08/2004
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
09/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2002
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2002
1Scoliosis
12/2001
1Fatigue
12/2001
1GATA2 Deficiency
12/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2001
1Pancreatitis
12/2001
1Endometrial Neoplasms (Endometrial Cancer)
12/2001
1Chronic Pancreatitis
12/2001
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2001

Drug/Important Bio-Agent (IBA)

4Vecuronium Bromide (Vecuronium)FDA LinkGeneric
01/2019 - 01/2002
4Photosensitizing Agents (Photosensitizers)IBA
10/2001 - 01/2000
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2001 - 01/2000
3AntigensIBA
09/2001 - 02/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 10/2000
2Messenger RNA (mRNA)IBA
09/2002 - 01/2000
2Protease Inhibitors (Protease Inhibitor)IBA
01/2002 - 06/2001
2LipidsIBA
11/2001 - 02/2001
2Prion ProteinsIBA
06/2001 - 11/2000
2TrehaloseIBA
02/2001 - 04/2000
2ATX-S10IBA
07/2000 - 01/2000
1Neuromuscular Blocking AgentsIBA
02/2014
1Pharmaceutical PreparationsIBA
02/2014
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2012
1acetylcelluloseIBA
01/2012
1Monoclonal AntibodiesIBA
06/2011
1Phosphates (Orthophosphate)IBA
06/2011
1Complement System Proteins (Complement)IBA
06/2011
1Transcription Factors (Transcription Factor)IBA
06/2011
1Alemtuzumab (Campath)FDA Link
06/2011
1Uric Acid (Urate)IBA
04/2011
1Interleukin-6 (Interleukin 6)IBA
04/2011
1HDL CholesterolIBA
04/2011
1Blood Proteins (Serum Proteins)IBA
03/2008
1Proteins (Proteins, Gene)FDA Link
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2008
1Pioglitazone (Actos)FDA Link
09/2007
1DNA (Deoxyribonucleic Acid)IBA
10/2006
1EnzymesIBA
10/2006
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2005
1CysteinyldopaIBA
08/2004
1HaptensIBA
09/2003
1Oxygen (Dioxygen)IBA
04/2003
1Nitrous Oxide (Laughing Gas)IBA
04/2003
1Fentanyl (Sublimaze)FDA LinkGeneric
04/2003
1IsofluraneFDA LinkGeneric
04/2003
1OxidesIBA
10/2002
1Proliferating Cell Nuclear Antigen (PCNA)IBA
09/2002
1Complementary DNA (cDNA)IBA
09/2002
1urinastatin (MR 20)IBA
01/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2001
1CorticosteroneIBA
12/2001
1Epirubicin (Ellence)FDA LinkGeneric
12/2001
1Carboplatin (JM8)FDA LinkGeneric
12/2001
1Tacrolimus (Prograf)FDA LinkGeneric
12/2001
1Prednisolone (Predate)FDA LinkGeneric
11/2001

Therapy/Procedure

4Intravenous Injections
06/2011 - 01/2000
3Therapeutics
01/2012 - 12/2001
3Photochemotherapy (Photodynamic Therapy)
10/2001 - 01/2000
3Semiconductor Lasers
10/2001 - 01/2000
2Renal Dialysis (Hemodialysis)
04/2011 - 12/2000
2Subcutaneous Injections
12/2001 - 11/2000
2Pedicle Screws
11/2000 - 01/2000
2Decompression
11/2000 - 01/2000
2Intravenous Administration
10/2000 - 07/2000
1Blood Component Removal (Apheresis)
01/2012
1Immunotherapy
06/2011
1Percutaneous Coronary Intervention
12/2009
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2009
1Oral Administration
10/2002
1Bone Screws
12/2001
1Drug Therapy (Chemotherapy)
12/2001